Medicine and Dentistry
Inpatient
100%
Percutaneous Coronary Intervention
87%
Rapamycin
71%
Patient
48%
Stent
47%
Combination Therapy
47%
Revascularization
40%
Therapeutic Procedure
25%
Polymer
24%
Umirolimus
23%
Coronary Occlusion
23%
Incidence
23%
Coronary Angiography
21%
Myocardial Infarction
21%
Follow up
19%
Heart Muscle Ischemia
19%
Ischemic Heart Disease
17%
Acute Coronary Syndrome
17%
Target Lesion
16%
ST Segment Elevation Myocardial Infarction
15%
Lesion
14%
Primary Percutaneous Coronary Intervention
13%
Amaurosis
12%
Stenosis
12%
Heart Death
12%
Coronary Computed Tomography Angiography
11%
Ticagrelor
11%
Conditioning
11%
Stable Angina Pectoris
11%
Heart Arrest
11%
Left Coronary Artery
11%
Female
11%
Isoprenaline
11%
Autosomal Dominant Inheritance
11%
Alcohol Consumption
11%
Gene
11%
Diabetes
11%
Randomized Controlled Trial
11%
Elastin
11%
Acute Heart Infarction
11%
Heart Muscle Revascularization
11%
Chronic Total Occlusion
11%
Prognosis
11%
Cardiac Dysrhythmia
11%
Percutaneous Intervention
11%
Drug Therapy
11%
Heart Failure
11%
All Cause Mortality
9%
Biological Marker
9%
Clopidogrel
9%
Pharmacology, Toxicology and Pharmaceutical Science
Sirolimus
71%
CD34 Antibody
47%
Polymer
24%
Stent
23%
Umirolimus
23%
Acute Coronary Syndrome
12%
Diabetes Mellitus
12%
Ticagrelor
11%
ST Segment Elevation Myocardial Infarction
11%
Study Design
11%
Coronary Artery Occlusion
11%
Pharmaceutical Therapy
11%
Heart Arrhythmia
11%
Clopidogrel
9%
Heart Infarction
7%
Incidence
7%
Heart Death
6%